Biotech Values

[jq1234]

That's likely the case. I was just talking about current situation without data. I would do a sequencing study on Zytiga treated patients if I were MDVN'S/Astellas. It doesn't have to be large or with survival endpoint, rather just PSA and other surrogate endpoints to see Xtandi's efficacy on Zytiga treated.